Analystreport

Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

Eiger BioPharmaceuticals, Inc.  (EIGR) 
Last eiger biopharmaceuticals, inc. earnings: 3/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.eigerbio.com